PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024.
Learn more - Pharmac announcement
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
PE/Dazzle™ 594 anti-human CD134 (OX40), 25 tests
PE/Dazzle™ 594 anti-human CD137 (4-1BB), 100 tests
PE/Dazzle™ 594 anti-human CD137 (4-1BB), 25 tests
PE/Dazzle™ 594 anti-human CD138 (Syndecan-1), 100 tests
PE/Dazzle™ 594 anti-human CD138 (Syndecan-1), 25 tests
PE/Dazzle™ 594 anti-human CD14, 100 tests
PE/Dazzle™ 594 anti-human CD14, 25 tests
PE/Dazzle™ 594 anti-human CD141 (Thrombomodulin), 100 tests
PE/Dazzle™ 594 anti-human CD141 (Thrombomodulin), 25 tests
PE/Dazzle™ 594 anti-human CD15 (SSEA-1), 100 tests
PE/Dazzle™ 594 anti-human CD15 (SSEA-1), 25 tests
PE/Dazzle™ 594 anti-human CD152 (CTLA-4), 100 tests
PE/Dazzle™ 594 anti-human CD152 (CTLA-4), 25 tests